The Bichat–Claude Bernard Hospital is located in the 18th arrondissement of Paris, France, and is operated by Assistance Publique – Hôpitaux de Paris. It was founded in 1881 as l'Hôpital Bichat, incorporating the units of nearby Hôpital Claude-Bernard upon the latter's demolition in 1970.

During the past decade, Hopital Bichat Claude Bernard conducted 201 clinical trials. In the 10-year time frame, 201 clinical trials started and 56 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 99 clinical trials started and 32 clinical trials were completed. i.e. 32.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Bichat Claude Bernard" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 68 trials, followed by "ANRS, Emerging Infectious Diseases" with 15 trials sponsored, "Gilead Sciences" with 13 trials sponsored, "Boehringer Ingelheim" with 11 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 11 trials sponsored. Other sponsors include 224 different institutions and companies that sponsored additional 143 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bichat Claude Bernard" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 7 trials as a collaborator, "Ministry of Health, France" with 5 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 187 different institutions and companies that were collaborators in the rest 173 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Bichat Claude Bernard" are "Colorectal Cancer" (9 trials), "HIV Infections" (9 trials), "HIV-1 Infection" (9 trials), "Heart Failure" (9 trials) and "Idiopathic Pulmonary Fibrosis" (8 trials). Many other conditions were trialed in "Hopital Bichat Claude Bernard" in a lesser frequency.

Most popular intervention types in "Hopital Bichat Claude Bernard" are "Drug" (160 trials), "Other" (68 trials), "Device" (46 trials), "Procedure" (31 trials) and "Biological" (26 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "fluorouracil" (10 trials), "Nintedanib" (8 trials), "leucovorin calcium" (8 trials) and "gemcitabine hydrochloride" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bichat Claude Bernard" are 316 trials for "All" genders, 18 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Bichat Claude Bernard". 5 are not yet recruiting, 66 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 183 completed trials in Hopital Bichat Claude Bernard, 1 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bichat Claude Bernard, 9 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 80 trials that are defined as “Not Applicable".